These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2656250)

  • 1. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil.
    Taurog A; Dorris ML
    Endocrinology; 1989 Jun; 124(6):3038-42. PubMed ID: 2656250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.
    Taurog A; Dorris ML; Guziec FS; Uetrecht JP
    Endocrinology; 1989 Jun; 124(6):3030-7. PubMed ID: 2656249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A; Taurog A; Engler H; Dorris ML
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
    Nakashima T; Taurog A; Riesco G
    Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.
    Engler H; Taurog A; Dorris ML
    Endocrinology; 1982 Jan; 110(1):190-7. PubMed ID: 7053983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 35S- and 14C-labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo.
    Taurog A; Dorris ML; Guziec FS
    Endocrinology; 1989 Jan; 124(1):30-9. PubMed ID: 2535809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of the thioureylene antithyroid drugs.
    Taurog A
    Endocrinology; 1976 Apr; 98(4):1031-46. PubMed ID: 1278093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selenium analog of 6-propylthiouracil. Measurement of its inhibitory effect on type I iodothyronine deiodinase and of its antithyroid activity.
    Taurog A; Dorris ML; Hu WX; Guziec FS
    Biochem Pharmacol; 1995 Mar; 49(5):701-9. PubMed ID: 7887985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antithyroid agents 6-propyl-2-thiouracil and 1-mehtyl-2-mercaptoimidazole on human thyroid iodine peroxidase.
    Nagasaka A; Hidaka H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):152-8. PubMed ID: 947933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs.
    Engler H; Taurog A; Luthy C; Dorris ML
    Endocrinology; 1983 Jan; 112(1):86-95. PubMed ID: 6847836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland.
    Taurog A; Dorris ML; Doerge DR
    Thyroid; 1996 Jun; 6(3):211-9. PubMed ID: 8837329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-catalyzed iodination and coupling.
    Taurog A; Dorris ML
    Arch Biochem Biophys; 1992 Jul; 296(1):239-46. PubMed ID: 1318692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat.
    Paul KB; Hedge JM; Macherla C; Filer DL; Burgess E; Simmons SO; Crofton KM; Hornung MW
    Toxicology; 2013 Oct; 312():97-107. PubMed ID: 23959146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of propylthiouracil analogs: comparison of 5'-deiodinase inhibition and antithyroid activity.
    Nogimori T; Braverman LE; Taurog A; Fang SL; Wright G; Emerson CH
    Endocrinology; 1986 Apr; 118(4):1598-605. PubMed ID: 3948793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase.
    Taurog A; Dorris ML; Doerge DR
    Arch Biochem Biophys; 1996 Jun; 330(1):24-32. PubMed ID: 8651700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methimazole and propylthiouracil increase cellular thyroid peroxidase activity and thyroid peroxidase mRNA in cultured porcine thyroid follicles.
    Sugawara M; Sugawara Y; Wen K
    Thyroid; 1999 May; 9(5):513-8. PubMed ID: 10365684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of iodotyrosine catalyzed by human thyroid peroxidase in vitro.
    Sugawara M
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1069-75. PubMed ID: 3838997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
    Motonaga K; Ota M; Odawara K; Saito S; Welsch F
    Regul Toxicol Pharmacol; 2016 Oct; 80():283-90. PubMed ID: 27350053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of plasma propylthiouracil levels with inhibition of thyroid hormone synthesis in the rat.
    Francis GL; Rennert OM
    Metabolism; 1980 May; 29(5):410-4. PubMed ID: 7374447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings.
    Davidson B; Soodak M; Neary JT; Strout HV; Kieffer JD; Mover H; Maloof F
    Endocrinology; 1978 Sep; 103(3):871-82. PubMed ID: 744122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.